These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 6609538)

  • 1. Exploiting biochemical differences in leukemia.
    Coleman MS; Grever MR
    Adv Exp Med Biol; 1984; 165 Pt B():315-20. PubMed ID: 6609538
    [No Abstract]   [Full Text] [Related]  

  • 2. Modulation of arabinosyladenine metabolism by 2'-deoxycoformycin in the therapy of human acute leukemia.
    Plunkett W; Nowak B; Feun LG; Benjamin RS; Keating M; Freirich EJ
    Adv Exp Med Biol; 1984; 165 Pt B():345-50. PubMed ID: 6372382
    [No Abstract]   [Full Text] [Related]  

  • 3. Adenosine deaminase in malaria infection: effect of 2'-deoxycoformycin in vivo.
    Webster HK; Wiesmann WP; Pavia CS
    Adv Exp Med Biol; 1984; 165 Pt A():225-9. PubMed ID: 6609525
    [No Abstract]   [Full Text] [Related]  

  • 4. [Successful treatment with 2'-deoxycoformycin in a case of adult T-cell leukemia].
    Ishii M; Yamaguchi K; Yul LS; Oda T; Takatsuki K
    Rinsho Ketsueki; 1986 May; 27(5):780-3. PubMed ID: 3018324
    [No Abstract]   [Full Text] [Related]  

  • 5. Purinogenic lymphocytotoxicity: clues to a wider chemotherapeutic potential for the adenosine deaminase inhibitors.
    Kefford RF; Fox RM
    Cancer Chemother Pharmacol; 1983; 10(2):73-8. PubMed ID: 6600985
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of acute lymphoblastic leukemia with the adenosine deaminase inhibitor 2'-deoxycoformycin.
    Mitchell BS; Koller CA; Kelley WN
    Adv Exp Med Biol; 1979; 122B():347-50. PubMed ID: 317568
    [No Abstract]   [Full Text] [Related]  

  • 7. The treatment of hairy cell leukemia (HCL) with pentostatin (2'-deoxycoformycin, dCF).
    Spiers AS; Parekh SJ
    Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():173-5. PubMed ID: 2653498
    [No Abstract]   [Full Text] [Related]  

  • 8. Adenosine deaminase in malaria infected erythrocytes: unique parasite enzyme presents a new therapeutic target.
    Wiesmann WP; Webster HK; Lambros C; Kelley WN; Daddona PE
    Prog Clin Biol Res; 1984; 165():325-42. PubMed ID: 6334315
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical utility of terminal deoxynucleotidyl transferase and adenosine deaminase determinations in adult leukemia with a lymphoid phenotype.
    Brusamolino E; Isernia P; Lazzarino M; Scovassi I; Bertazzoni U; Bernasconi C
    J Clin Oncol; 1984 Aug; 2(8):871-80. PubMed ID: 6589363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical relevance of terminal transferase and adenosine deaminase in leukemia.
    Brusamolino E; Bertazzoni U; Isernia P; Ginelli E; Scovassi AI; Zurlo MG; Plevani P; Sacchi N; Bernasconi C
    Adv Exp Med Biol; 1982; 145():279-303. PubMed ID: 7051780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current status of clinical trials of m-AMSA, dihydroxyanthracenedione, and deoxycoformycin.
    Macdonald JS; Marsoni S; Bruno S; Poster D
    Recent Results Cancer Res; 1982; 80():323-30. PubMed ID: 6977170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Remission induction with adenosine-deaminase inhibitor 2'-deoxycoformycin in Thy-lymphoblastic leukaemia.
    Prentice HG; Smyth JF; Ganeshaguru K; Wonke B; Bradstock KF; Janossy G; Goldstone AH; Hoffbrand AV
    Lancet; 1980 Jul; 2(8187):170-2. PubMed ID: 6105339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo inhibition of adenosine deaminase by 2'-deoxycoformycin in mouse blood and leukemia L1210 cells.
    Agarwal RP
    Biochem Pharmacol; 1980 Feb; 29(2):187-93. PubMed ID: 6965857
    [No Abstract]   [Full Text] [Related]  

  • 14. Pentostatin (2'deoxycoformycin) for the treatment of lymphoid neoplasms.
    Ho AD; Thaler J; Willemze R; Lauria F; Derossi G; Kuse R; Stryckmans P; Blanc CM; Cataldo F; McVie G
    Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():60-2. PubMed ID: 2653520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deoxycoformycin antagonizes ischemia-induced neuronal degeneration.
    Phillis JW; O'Regan MH
    Brain Res Bull; 1989 Mar; 22(3):537-40. PubMed ID: 2785431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conversion of a stem cell leukemia from a T-lymphoid to a myeloid phenotype induced by the adenosine deaminase inhibitor 2'-deoxycoformycin.
    Hershfield MS; Kurtzberg J; Harden E; Moore JO; Whang-Peng J; Haynes BF
    Proc Natl Acad Sci U S A; 1984 Jan; 81(1):253-7. PubMed ID: 6607471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The activity of deoxycoformycin (pentostatin) in refractory leukemias and lymphomas.
    Spiers AS
    Ann N Y Acad Sci; 1985; 451():138-41. PubMed ID: 3878115
    [No Abstract]   [Full Text] [Related]  

  • 18. Repeated pentostatin (2'deoxycoformycin)-induced remissions in a patient with advanced chronic lymphocytic leukemia.
    Dillman RO; Yu AL; Qiao CN
    West J Med; 1988 Mar; 148(3):334-7. PubMed ID: 3259051
    [No Abstract]   [Full Text] [Related]  

  • 19. Complete remission in hairy cell leukaemia achieved with pentostatin.
    Spiers AS; Parekh SJ
    Lancet; 1984 May; 1(8385):1080-1. PubMed ID: 6144012
    [No Abstract]   [Full Text] [Related]  

  • 20. Pentostatin in chronic lymphocytic leukemia: a phase II trial of Cancer and Leukemia group B.
    Dillman RO; Mick R; McIntyre OR
    J Clin Oncol; 1989 Apr; 7(4):433-8. PubMed ID: 2784491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.